SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up -- Ignore unavailable to you. Want to Upgrade?


To: Ron Kline who wrote (839)5/4/1998 10:35:00 PM
From: ron keller  Read Replies (2) | Respond to of 1055
 
I added to my position as well today. News reports indicate that human trials for Entremed's cancer treatment may start as early as the end of this year and IF everything goes perfectly, one to three years for general availability of the drug for treatment. Let's hope THRX continues its progress toward alternative uses for its seeds in the treatment of different kinds of cancer and remains a leader it field.

Ron